CN106581311A - 治疗慢性鼻炎的药物 - Google Patents
治疗慢性鼻炎的药物 Download PDFInfo
- Publication number
- CN106581311A CN106581311A CN201610990145.XA CN201610990145A CN106581311A CN 106581311 A CN106581311 A CN 106581311A CN 201610990145 A CN201610990145 A CN 201610990145A CN 106581311 A CN106581311 A CN 106581311A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- chinese
- glucocorticoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 201000009151 chronic rhinitis Diseases 0.000 title claims abstract description 27
- 229940079593 drug Drugs 0.000 title claims abstract description 25
- 206010039083 rhinitis Diseases 0.000 title abstract description 11
- 239000003862 glucocorticoid Substances 0.000 claims abstract description 23
- 241000132012 Atractylodes Species 0.000 claims abstract description 20
- 240000003146 Lobelia chinensis Species 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 241000756943 Codonopsis Species 0.000 claims description 17
- 239000009636 Huang Qi Substances 0.000 claims description 17
- 240000006688 Telosma cordata Species 0.000 claims description 17
- 235000017352 Telosma cordata Nutrition 0.000 claims description 17
- 206010047700 Vomiting Diseases 0.000 claims description 17
- 241001251949 Xanthium sibiricum Species 0.000 claims description 17
- 230000008673 vomiting Effects 0.000 claims description 17
- 244000246386 Mentha pulegium Species 0.000 claims description 16
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 16
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 16
- 235000001050 hortel pimenta Nutrition 0.000 claims description 16
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 15
- 241000178435 Eliokarmos dubius Species 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000011505 plaster Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 238000007654 immersion Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 240000002045 Guettarda speciosa Species 0.000 claims 3
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract description 3
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 241001180873 Saposhnikovia divaricata Species 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 241001506766 Xanthium Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 1
- 206010042674 Swelling Diseases 0.000 description 19
- 230000008961 swelling Effects 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 15
- 230000036407 pain Effects 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 210000001331 nose Anatomy 0.000 description 13
- 241000125175 Angelica Species 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 206010028748 Nasal obstruction Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000000306 recurrent effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 208000036071 Rhinorrhea Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 208000004078 Snake Bites Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 230000001114 myogenic effect Effects 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 241000158526 Nasalis Species 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000003356 anti-rheumatic effect Effects 0.000 description 3
- 239000003435 antirheumatic agent Substances 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 208000003512 furunculosis Diseases 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 239000007922 nasal spray Substances 0.000 description 3
- 229940097496 nasal spray Drugs 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 201000009890 sinusitis Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010018691 Granuloma Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000000850 decongestant Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- HVYLDJKDVOOTHV-UHFFFAOYSA-N acetic acid;2-iminoethanethiol Chemical compound CC(O)=O.CC(O)=O.SCC=N HVYLDJKDVOOTHV-UHFFFAOYSA-N 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 210000000959 ear middle Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 229960005016 naphazoline Drugs 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 201000008006 pharynx cancer Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 206010044652 trigeminal neuralgia Diseases 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 208000025301 tympanitis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种治疗慢性鼻炎的药物,包括以下重量份的原料:苍耳子16‑20份、薄荷14‑18份、天葵子12‑14份、黄芪20‑24份、党参10‑14份、白术6‑10份、黄丹2‑6份、地丁8‑12份、白蛇花草12‑16份、马钱子12‑16份、半边莲6‑10份、白芷12‑14份,山茱萸10‑14份,狗脊6‑10份、防风4‑6份,糖皮质激素0.001‑0.003份。本发明的药物能够有效治疗慢性鼻炎。
Description
技术领域
本发明涉及药物领域,具体是涉及一种治疗慢性鼻炎的药物。
背景技术
鼻炎对身体的损害以慢性鼻炎、鼻窦炎和副鼻窦炎为最严重,尤其对儿童危害极大,甚至有生命危险。慢性鼻炎、鼻窦炎患者,由于鼻腔阻塞,往往无奈之下用滴鼻净和西药抗生素,会对鼻腔粘膜造成终身损害,破坏防护屏障,一生中鼻炎,鼻窦炎会每年十几次、几十次反复发作,令人痛苦终生。会引起记忆力减退、智力下降、周期性头痛、头昏、而且每次发作均会比以前加重,十分痛苦。慢性鼻窦炎、副鼻窦炎很容易诱发脑膜炎,脑水肿并对神视神经、听神经产生破坏,引起视力、听力下降、脑膜炎等则容易导致生命危险。鼻、咽癌变,80%左右与慢性鼻炎有关。
中医学中临床常依症状分为肺脾气虚型和气滞血滞型。肺脾气虚型主证:鼻塞时轻时重,鼻涕清稀,遇寒加重,嗅觉减退,头痛,头晕。检查见鼻内肿胀色淡。肺气虚者兼见咳嗽痰稀,面色(白光)白,舌淡苔白,脉缓或沉细。脾气虚者兼见食欲不佳,体倦乏力,舌质淡,苔白或厚,脉濡缓。气滞血淤型主证:鼻塞时间长,鼻涕多,粘黄或粘白,嗅觉迟钝,检查见鼻内肿胀,呈桑椹样。伴咳嗽痰多,声音重浊,舌资暗红有淤斑,脉弦细或涩数。
本病的病机主要由于肺气虚,卫表不固,邪气乘虚而入,犯及鼻窍,邪正相搏,肺气不得通调,津液停聚,鼻窍壅塞,遂至发为本病。或因本病反复发作郁而化热,或因患者体质属木火类而感受寒湿之邪。故治疗宜行滞化瘀、温肺散结、利尿通淋、祛风通窍。
目前,临床上治疗慢性鼻炎一般采用局部糖皮质激素鼻喷雾剂,可以在炎症的各个阶段都发挥强大的抗炎、抗水肿效应,并能促进损伤的纤毛上皮修复,是目前治疗鼻黏膜炎症性疾病的一线药物。减充血剂只有在慢性鼻炎伴发急性感染时才可使用减充血剂滴鼻,1~2次/天,并且一般应用时间不宜超过7~10天,此类药物长期使用可引起药物性鼻炎。儿童可短期应用浓度较低的此类药物。中医中采用封闭疗法可作迎香穴和鼻通穴封闭;也可作鼻丘或双侧下鼻甲前段黏膜下注射。但此种方法目前已很少应用。然而仅从西医消炎角度治疗慢性鼻炎,见效慢,尤其是身体再出现炎症时容易将炎症转移至鼻腔,再复发性高,并且药物制备工艺复杂,如果治疗不及时、不彻底,还有可能导致药物性鼻炎,治愈更加困难。
发明内容
本发明要解决的技术问题在于提供一种能够有效治疗慢性鼻炎的中西医结合的药物,制备工艺简单、疗程短、见效快、费用低、使用方便、并且不易复发。
为解决上述问题,本发明公开一种治疗慢性鼻炎的药物,由以下重量份的原料制成:
苍耳子16-20份、薄荷14-18份、天葵子12-14份、黄芪20-24份、党参10-14份、白术6-10份、黄丹2-6份、地丁8-12份、白蛇花草12-16份、马钱子12-16份、半边莲6-10份、白芷12-14份,山茱萸10-14份,狗脊6-10份、防风4-6份、糖皮质激素0.001-0.003份。
优选的,所述药物包括:苍耳子18份、薄荷16份、天葵子14份、黄芪22份、党参12份、白术8份、黄丹4份、地丁10份、白蛇花草14份、马钱子14份、半边莲8份、白芷12份,山茱萸12份,狗脊8份、防风5份、糖皮质激素0.002份。
优选地,本发明的治疗慢性鼻炎的药物,是经过以下步骤制得:
(1)取苍耳子、薄荷、天葵子,粉碎后加水煎煮,煎煮前浸泡2小时,然后加热至沸腾并煎煮0.5小时,过滤分离出滤液,将滤渣按所述煎煮步骤再次进行煎煮2次,合并滤液,浓缩至55℃相对密度为1.10-1.15的浓缩液备用;
(2)取黄芪、党参、白术、地丁、白蛇花草、马钱子、半边莲、白芷,山茱萸,狗脊、防风粉碎磨细,过40-60目筛,混合得细粉,加水煎煮2次,每次0.5小时,合并滤液,浓缩至55℃相对密度为1.20-1.25的浓缩液备用;
(3)糖皮质激素加入0.lmol/L盐酸溶液适量溶解,再加入适量乙醇溶液充分搅拌均匀;
(4)步骤(3)中溶液加入研磨成细粉的黄丹,再将步骤(1)和(2)制得的浓缩液与混有黄丹的糖皮质激素溶液搅拌均匀,浓缩去除部分水分及乙醇后得到贴膏剂。
优选地,使用时先用消毒棉签将耳道洗拭干净,以纸卷成细管或用细塑料管摄入权利要求1-4之一所述粉末,吹入耳道深部,每天一次到两次。
本发明所用药材药理药效为:
中医认为本病的病机主要由于肺气虚,卫表不固,邪气乘虚而入,犯及鼻窍,邪正相搏,肺气不得通调,津液停聚,鼻窍壅塞,遂至发为本病。或因本病反复发作郁而化热,或因患者体质属木火类而感受寒湿之邪。故治疗宜行滞化瘀、温肺散结、利尿通淋、祛风通窍,对慢性鼻炎有显著的防治作用。
苍耳子:散风寒,通鼻窍,祛风湿,止痒。主治鼻渊,风寒头痛,风湿痹痛,风疹,湿疹,疥癣。
薄荷:清新怡神,疏风散热,增进食欲,帮助消化,可治疗伤风鼻塞、打喷嚏、流鼻涕等症。发汗散气,消风消肿。
天葵子:归肝、胃经。清热解毒,消肿散结。用于痈肿疔疮,乳痈,瘰疬,蛇虫咬伤。
黄丹:坠痰去怯,故治惊癫狂、吐逆反胃有奇故;能消积杀虫,故汉疳疾、下痢、疟疾有实绩;能解热、拔毒、长肉、去瘀,故治恶疮肿毒及入膏药。
黄芪:补齐固表,托疮生肌。黄芪有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。用于治疗气虚乏力,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴,慢性肾炎,蛋白尿,糖尿病等。炙黄芪益气补中,生用固表托疮。
党参:健脾补肺、益气生津。主脾胃虚弱、食少便溏、四肢乏力、肺虚喘咳、气短自汗、气微两亏诸证。《中药材手册》:治虚劳内伤,肠胃中冷,滑泻久痢,气喘烦渴,发热自汗,妇女血崩、胎产诸病。《本草正义》:党参力能补脾养胃,润肺生津,腱运中气,本与人参不甚相远。
白术:健脾益气;燥湿利水;止汗;安胎。主脾气虚弱;神疲乏力;食少少腹胀;大便溏薄;水饮内停。白术可以统血而收阴;阳虚而汗液不收,白术可以回阳而敛汗。
地丁:性味苦,寒,入心、肝经,有清热利湿,解毒消肿的功能,治疔疮,痈肿,瘰疬,黄疸,痢疾,腹泻,目赤,喉痹,毒蛇咬伤。
白花蛇舌草:性味苦甘,寒,入心、肝、脾三经,有清热,利湿,解毒的功能,治肺热喘咳,扁桃体炎,咽喉炎,阑尾炎,痢疾,黄疸,盆腔炎,附件炎,痈肿疔疮,毒蛇咬伤。
马钱子:通络止痛:用治风湿顽痹或拘挛麻木。消肿散结:用治外伤瘀肿疼痛及痈疽肿痛。近年用治多种癌肿,有一定疗效。治疗小儿麻痹后遗症,腰椎间盘突出症,三叉神经痛,类风湿性关节炎,跌打损伤、瘀血疼痛,风寒湿痹、全身关节拘急、麻木,癌肿等。主治咽喉痹痛,痈疽肿毒,风痹疼痛,骨折,面神经麻痹,重症肌无力。
半边莲:归心、小肠、肺经。利尿消肿,清热解毒。用于大腹水肿,面足浮肿,痈肿疔疮,蛇虫咬伤;晚期血吸虫病腹水。
白芷,性味辛、温,归肺、胃经。主治祛风散寒,通窍止痛,活血排脓,生肌止痛,燥湿止带。
山茱萸具有补益肝肾、涩精固脱的功效。
狗脊具有祛风湿、补肝肾、强腰膝的功效。主治风湿痹痛,腰膝酸软,下肢无力。
防风:味辛、甘,性微温。归膀胱、肝、脾经。祛风解表,胜湿止痛,止痉定搐。外感表证,风疹瘙痒,风湿痹痛,破伤风。
糖皮质激素:主要用于上述革兰阴性菌所致的呼吸道、咽喉、扁桃体、泌尿道(包括前列腺)、皮肤及软组织、胆囊及胆管、中耳、鼻窦、泪囊、肠道等部位的急、慢性感染。
本发明中苍耳子主要用于散寒通窍、祛湿止痒、祛风消肿;薄荷发汗散气,消风消肿;黄丹能解热、拔毒、长肉、去瘀,入膏药,是外科必用的药物。天葵子:清热解毒,消肿散结。黄芪具有甘油具有益气固表、利水消肿之功效。党参:健脾补肺、益气生津。白术具有健脾益气、燥湿利水之效。地丁有清热利湿,解毒消肿的功能。白花蛇舌草有清热,利湿,解毒的功能。马钱子具有通络止痛、消肿散结等功效。半边莲利尿消肿,清热解毒。白芷祛风散寒,通窍止痛,活血排脓,生肌止痛,燥湿止带。山茱萸具有补益肝肾、涩精固脱的功效。狗脊具有祛风湿、补肝肾、强腰膝的功效。防风祛风解表,胜湿止痛,止痉定搐。糖皮质激素为西药治疗中耳炎的抗炎药物。诸药合用,共奏清热解毒、抗菌消炎、消肿止痛、收敛燥湿之功。
本发明中药组方是以苍耳子、马钱子、防风为君药,主要用于散寒通窍、祛湿止痒、祛风消肿;以天葵子、半边莲、白花蛇草、地丁、白芷为臣药,清热解毒,消肿散结;以黄芪、党参、薄荷、山茱萸、狗脊为佐药,益气固表、发汗散气、利水消肿、健脾生津,助补气生阴之力;以白术为使药,达到健脾益气、燥湿利水的目的;同时,利用黄丹将诸药入膏药。君臣佐使诸药配合,辅以糖皮质激素,凸显其抗菌消炎之效,利用中西药结合的相互补充之效,协同作用,互为辅助,共同达到健脾渗湿,排脓解毒,抗菌消炎等功效,对慢性鼻炎具有十分显著的疗效。
本发明具有下述优点:
本发明选用天然中药为原料,采用各味中药的综合作用来治疗慢性鼻炎,无任何毒副作用,且不会对人体造成损伤。可以清热解毒、消肿止痛、收敛燥湿、抗菌消炎,标本兼治。中西药结合,能够有效治疗慢性鼻炎,制备工艺简单、疗程短、见效快。临床实验表明,该中药组合物对于慢性鼻炎有较好的治疗效果,总有效率为96%,且治愈后不易复发,具有广泛的应用价值。
具体实施方式
以下通过特定的具体实例说明本发明的实施方式,本领域技术人员可由本说明书所揭露的内容轻易地了解本发明的其他优点与功效。本发明还可以通过另外不同的具体实施方式加以实施或应用,本说明书中的各项细节也可以基于不同观点与应用,在没有背离本发明的精神下进行各种修饰或改变。
在进一步描述本发明具体实施方式之前,应理解,本发明的保护范围不局限于下述特定的具体实施方案;还应当理解,本发明实施例中使用的术语是为了描述特定的具体实施方案,而不是为了限制本发明的保护范围;在本发明说明书和权利要求书中,除非文中另外明确指出,单数形式“一个”、“一”和“这个”包括复数形式。
当实施例给出数值范围时,应理解,除非本发明另有说明,每个数值范围的两个端点以及两个端点之间任何一个数值均可选用。除非另外定义,本发明中使用的所有技术和科学术语与本技术领域技术人员通常理解的意义相同。除实施例中使用的具体方法、设备、材料外,根据本技术领域的技术人员对现有技术的掌握及本发明的记载,还可以使用与本发明实施例中所述的方法、设备、材料相似或等同的现有技术的任何方法、设备和材料来实现本发明。
下文结合具体实施例和对比例对本发明的临床效果进行详细说明。
实施例1
(1)取苍耳子18g、薄荷16g、天葵子14g,粉碎后加水煎煮,煎煮前浸泡2小时,然后加热至沸腾并煎煮0.5小时,过滤分离出滤液,将滤渣按所述煎煮步骤再次进行煎煮2次,合并滤液,浓缩至55℃相对密度为1.10-1.15的浓缩液备用;
(2)取黄芪22g、党参12g、白术8g、地丁10g、白蛇花草14g、马钱子14g、半边莲8g、白芷12g,山茱萸12g,狗脊8g、防风5g粉碎磨细,过40-60目筛,混合得细粉,加水煎煮2次,每次0.5小时,合并滤液,浓缩至55℃相对密度为1.20-1.25的浓缩液备用;
(3)糖皮质激素0.002g加入0.lmol/L盐酸溶液适量溶解,再加入适量乙醇溶液充分搅拌均匀;
(4)步骤(3)中溶液加入研磨成细粉的黄丹4g,再将步骤(1)和(2)制得的浓缩液与混有黄丹的糖皮质激素溶液搅拌均匀,浓缩去除部分水分及乙醇后得到贴膏剂。
对比例1
(1)取苍耳子14g、薄荷12g、天葵子18g,粉碎后加水煎煮,煎煮前浸泡2小时,然后加热至沸腾并煎煮0.5小时,过滤分离出滤液,将滤渣按所述煎煮步骤再次进行煎煮2次,合并滤液,浓缩至55℃相对密度为1.10-1.15的浓缩液备用;
(2)取黄芪30g、党参18g、白术16g、地丁10g、白蛇花草14g、马钱子14g、半边莲8g、白芷12g,山茱萸12g,狗脊8g、防风5g粉碎磨细,过40-60目筛,混合得细粉,加水煎煮2次,每次0.5小时,合并滤液,浓缩至55℃相对密度为1.20-1.25的浓缩液备用;
(3)糖皮质激素0.002g加入0.lmol/L盐酸溶液适量溶解,再加入适量乙醇溶液充分搅拌均匀;
(4)步骤(3)中溶液加入研磨成细粉的黄丹4g,再将步骤(1)和(2)制得的浓缩液与混有黄丹的糖皮质激素溶液搅拌均匀,浓缩去除部分水分及乙醇后得到贴膏剂。
对比例2
苍耳子18g、薄荷16g、天葵子14g、党参32g、白术10g、黄丹6g、地丁10g、白蛇花草14g、马钱子14g、半边莲8g、白芷12g,山茱萸12g,狗脊8g、防风5g、糖皮质激素0.002g,方法同实施例1。
对比例3
苍耳子18g、薄荷30g、天葵子10g、黄芪8g、党参24g、白术12g、黄丹8g、地丁10g、白蛇花草14g、马钱子14g、半边莲8g、白芷12g,山茱萸12g,狗脊8g、防风5g、糖皮质激素0.002g,方法同实施例1。
对比例4
苍耳子13g、薄荷26g、天葵子16g、黄芪26g、党参8g、白术8g、黄丹4g、地丁10g、白蛇花草14g、马钱子14g、半边莲8g、白芷12g,山茱萸12g,狗脊8g、防风5g、糖皮质激素0.002g,方法同实施例1。
对比例5
苍耳子18g、薄荷24g、黄芪12g、党参22g、白术14g、黄丹4g、地丁10g、白蛇花草14g、马钱子14g、半边莲8g、白芷12g,山茱萸12g,狗脊8g、防风5g、糖皮质激素0.002g,方法同实施例1。
对比例6
苍耳子24g、天葵子24g、黄芪22g、党参12g、白术12g、黄丹6g、地丁10g、白蛇花草14g、马钱子14g、半边莲8g、白芷12g,山茱萸12g,狗脊8g、防风5g、糖皮质激素0.002g,方法同实施例1。
对比例7
苍耳子24g、薄荷16g、天葵子18g、黄芪22g、党参16g、白术8g、黄丹4g、地丁10g、白蛇花草14g、马钱子14g、半边莲8g、白芷12g,山茱萸12g,狗脊8g、防风5g,方法同实施例1。
对上述实施例和对比例中制得的药物进行药效测试。
一、本发明外用制剂抗菌试验
实验材料
1、受试动物:昆明种小鼠,18-22g,雌雄各半。2、细菌和病毒:细菌菌株均为临床分离株;流感病毒鼠肺适应株FMl株。3、培养基板:MH培养基;肺炎链球菌采用血培养基,即在MH培养基中加入5%脱纤维羊血制成;流感嗜血杆菌采用巧克力培养基。
2、体外抗菌试验
(1)实验方法:受试药(本发明实施例1)制备成贴膏剂前,将黄丹同步骤2中一起煎煮,滤液合并用灭菌生理盐水稀释至下列浓度梯度,放至无菌平皿中,再加入灭菌MH培养基,混匀后冷却备用,使得物平板中药物的最终浓度为160、80、40、20、10、5、2.5、1.25、0.625、0.313(mg/ml)。同时设空白对照组。试验菌于37℃恒温培养24小时观察结果,并记录MIC值。
表1体外抗菌作用
(2)实验结果
体外抗菌试验结果表1表明,本发明实施例1中药物对临床致病菌均具有抑制作用,其中对金黄色葡萄球菌、表皮葡萄球菌、大肠杆菌、肺炎链球菌、肺炎克雷伯菌、嗜血流感杆菌、绿脓杆菌、伤寒杆菌和甲型副伤寒杆菌的MIC50分别为13、18、12、7、24、34、30、25和50mg/ml。
二、实验例对大鼠肉芽组织增生试验的影响
1、实验方法
分组:将健康SD大鼠,雌雄各半,体重180±20g,随机分为治疗组1-8组,每组10只,模型组1组8只;阳性组的8只。
治疗组1-8组每天涂抹本发明实施例1及对比例1-7制备贴膏剂;模型组每天给予生理盐水3.5ml;阳性组使用局部糖皮质激素鼻喷雾剂,每日2 次,连续操作15天。观察各组致炎后肉芽组织增生的情况。
造模:将豚鼠右部腋下去毛,75%乙醇消毒,做一个切口,皮下置入一个高温灭菌棉球,随后缝合,24h后开始涂药,每日3次,连续给药7天后,将大鼠处死,取出棉球肉芽肿组织,细心剥离脂肪组织,置60℃干燥4h,计算肉芽组织重量和肉芽抑制率。
2、结果
造模后第2天,豚鼠活动饮食良好,模型组显示出肉眼可见的肉芽肿涨,治疗组肉芽肿存在,但较模型组明显减弱。
肉芽肿胀:模型组非常明显,治疗组则有不同程度减轻,表明实施例1或对比例1-7制备粉剂对实验性炎症有一定的治疗作用,实施例1对炎症症的治疗作用明显优于对比例1-7组中的效果,见表2。
表2豚鼠肉芽肿胀程度比较
上述结果提示:本发明中药制剂连续应用15天,未见心、肝、肾有明显病理组织学改变。豚鼠肉芽肿胀检测结果表明,用药后,实施例1用药组肉芽肿胀程度有明显降低,相对于对比例1-7组,降低幅度更为明显。
三、部分临床资料:
1、病例选择与分组:全部100例,选择医院病房及门诊就诊的符合中医鼻窒气滞血瘀型患者,病程3个月至5年,单纯性鼻炎57例、肥厚性鼻炎43例。
随机分为治疗组和对照组。其中:治疗组50人;对照组50人。两组年龄、性别、病程、临床表现及病情严重程度比较差异均无统计学意义(p>0.05)。
2、诊断依据及纳入标准:
参照《中药新药临床研究指导原则》及国家中医药管理局1994-06-28颁布《中医病证诊断标准》、普通高等教育“十五”国家级规划教材《中医耳鼻咽喉科学》(第一版)及全国高等学校《耳鼻咽喉-头颈外科学》制定本研究的诊断标准、纳入标准、排除标准。
气滞血瘀症候辨证标准:鼻塞多为持续性,鼻涕粘稠,不易擤出,嗅觉迟钝。伴头昏、耳鸣、记忆力减退等症。鼻粘膜充血,呈暗红或深红色。鼻甲肿大,表面不平滑,如桑椹样,触之较硬,缺乏弹性,对一般滴鼻剂收缩反应较差。舌质紫暗或有瘀点,脉涩。
3、排除标准:
重症高血压、心绞痛、心功能不全或心律失常患者,重症糖尿病、甲状腺疾病或肝肾功能不全者。
4、治疗方法:
治疗组:用药前,先将鼻上部用湿布擦净,膏药加热变软后,贴于鼻上部,两小时后揭下,每日1次,15天1疗程;
对照组:局部糖皮质激素鼻喷雾剂,每日2次,15天1疗程。
5、疗效判断标准:
临床治愈:鼻塞、流涕、头胀痛等症状消失,嗅觉恢复正常。专科检查:鼻黏膜充血肿胀明显减轻,中、下鼻甲无明显充血、肿大。
有效:鼻塞、流涕、头胀痛等症状明显减轻。专科检查:鼻黏膜充血肿胀减轻,中、下鼻甲充血,肿大明显减轻。
无效:治疗前后症状体征无变化。。
6、治疗结果:两组分别治疗1个疗程后,统计结果参见表3。从表3可以看出,采用本发明的中药治疗慢性鼻炎,相对于西药在治疗效果上,具有显著的改进。
表3两组分别治疗1个疗程后临床疗效比较例
| 治愈 | 有效 | 无效 | 总有效 | ||
| 治疗组 | 50 | 32 | 16 | 2 | 96% |
| 对照组 | 50 | 20 | 24 | 6 | 88% |
鼻塞、鼻涕明显减少,鼻粘膜红色血肿胀程度减弱,同时感冒、头昏失眠、记忆力下降等症状出现的程度有明显减少。
四、具体病例
李某,女,21岁,患慢性鼻炎2年,鼻腔检查显示,鼻粘膜肿胀,下鼻道有脓性分泌物,鉴定为慢性单纯性鼻炎,服用多种鼻炎药物,反复发作,用药后鼻塞、流涕等临床症状明显改善,用药4个疗程,鼻塞等临床症状消失,理化检测指标基本正常,随访一年无复发。
赵某某,男,39岁,患慢性鼻炎3年,鼻腔检查显示,下鼻甲明显肥大,鼻腔底部有粘液性,粘膜肿胀,呈紫红色,表面不平,探针轻压凹陷不明显,触之有硬实感,诊断为慢性肥厚性鼻炎,用药后鼻塞、流涕等临床症状明显改善,用药4个疗程,鼻塞等临床症状消失,理化检测指标基本正常,随访一年无复发。
上面对本发明优选的具体实施方式和实施例作了详细说明,但是本发明并不限于上述实施方式和实施例,在本领域技术人员所具备的知识范围内,还可以在不脱离本发明构思的前提下作出各种变化。
Claims (5)
1.一种治疗慢性鼻炎的药物,其特征在于包括以下重量份的原料:
苍耳子16-20份、薄荷14-18份、天葵子12-14份、黄芪20-24份、党参10-14份、白术6-10份、黄丹2-6份、地丁8-12份、白蛇花草12-16份、马钱子12-16份、半边莲6-10份、白芷12-14份,山茱萸10-14份,狗脊6-10份、防风4-6份、糖皮质激素0.001-0.003份。
2.根据权利要求1所述的治疗慢性鼻炎的药物,其特征在于包括以下重量份的原料:
苍耳子18份、薄荷16份、天葵子14份、黄芪22份、党参12份、白术8份、黄丹4份、地丁10份、白蛇花草14份、马钱子14份、半边莲8份、白芷12份,山茱萸12份,狗脊8份、防风5份、糖皮质激素0.002份。
3.根据权利要求1所述的治疗慢性鼻炎的药物,其特征在于经过以下步骤制得:
(1)取苍耳子、薄荷、天葵子,粉碎后加水煎煮,煎煮前浸泡2小时,然后加热至沸腾并煎煮0.5小时,过滤分离出滤液,将滤渣按所述煎煮步骤再次进行煎煮2次,合并滤液,浓缩至55℃相对密度为1.10-1.15的浓缩液备用;
(2)取黄芪、党参、白术、地丁、白蛇花草、马钱子、半边莲、白芷,山茱萸,狗脊、防风粉碎磨细,过40-60目筛,混合得细粉,加水煎煮2次,每次0.5小时,合并滤液,浓缩至55℃相对密度为1.20-1.25的浓缩液备用;
(3)糖皮质激素加入0.lmol/L盐酸溶液适量溶解,再加入适量乙醇溶液充分搅拌均匀;
(4)步骤(3)中溶液加入研磨成细粉的黄丹,再将步骤(1)和(2)制得的浓缩液与混有黄丹的糖皮质激素溶液搅拌均匀,浓缩去除部分水分及乙醇后得到贴膏剂。
4.根据权利要求1-3之一所述的药物在制备治疗慢性鼻炎药物中的应用。
5.根据权利要求4所述应用,用药前,先将鼻上部用湿布擦净,膏药加热变软后,贴于鼻上部,两小时后揭下。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610990145.XA CN106581311A (zh) | 2016-11-10 | 2016-11-10 | 治疗慢性鼻炎的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610990145.XA CN106581311A (zh) | 2016-11-10 | 2016-11-10 | 治疗慢性鼻炎的药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106581311A true CN106581311A (zh) | 2017-04-26 |
Family
ID=58590752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610990145.XA Withdrawn CN106581311A (zh) | 2016-11-10 | 2016-11-10 | 治疗慢性鼻炎的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106581311A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1368187A (zh) * | 2001-01-31 | 2002-09-11 | 杨孟君 | 纳米通窍鼻炎制剂药物及其制备方法 |
| CN105999033A (zh) * | 2016-06-27 | 2016-10-12 | 李玲 | 一种用于护理慢性鼻炎的中药组合物 |
-
2016
- 2016-11-10 CN CN201610990145.XA patent/CN106581311A/zh not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1368187A (zh) * | 2001-01-31 | 2002-09-11 | 杨孟君 | 纳米通窍鼻炎制剂药物及其制备方法 |
| CN105999033A (zh) * | 2016-06-27 | 2016-10-12 | 李玲 | 一种用于护理慢性鼻炎的中药组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104352587A (zh) | 一种治疗鼻炎的软膏 | |
| CN102614306A (zh) | 治疗慢性鼻窦炎的中药制剂 | |
| CN110721303A (zh) | 一种治疗过敏性鼻炎的中药组合物及其应用 | |
| CN102716261B (zh) | 一种祛风湿中药药粉 | |
| CN104147194B (zh) | 一种治疗慢性鼻窦炎的中药组合物 | |
| CN106361828A (zh) | 治疗鼻炎的中药药膏 | |
| CN104491806A (zh) | 一种治疗过敏性鼻炎的外用中药药物 | |
| CN106581311A (zh) | 治疗慢性鼻炎的药物 | |
| CN102600272A (zh) | 一种治疗骨科疾病的中药 | |
| CN107496879A (zh) | 一种天灸中药及其制备方法与应用 | |
| CN107812084A (zh) | 一种治疗过敏性鼻炎的中药组合物及其制剂和应用 | |
| CN101804182B (zh) | 一种治疗鼻窦炎的中药 | |
| CN101129718B (zh) | 治疗白癜风的中药制剂 | |
| CN105726634A (zh) | 一种治疗鼻炎病的中药制剂 | |
| CN103736014A (zh) | 一种治疗前列腺增生症的中药组合物 | |
| CN101342252B (zh) | 一种治疗颈淋巴结核的鼻栓剂 | |
| CN106511574A (zh) | 治疗风寒湿型颈椎病的中药外敷贴 | |
| CN101069706B (zh) | 一种治疗鼻窦炎的药物 | |
| CN106074992A (zh) | 一种治疗胸部跌打伤的内服草药及其使用方法 | |
| CN106728273A (zh) | 一种祛痘的中药组合物 | |
| CN106266260A (zh) | 一种治疗颈腰椎病的丸剂药物及其制备方法 | |
| CN104825808A (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
| CN101829286B (zh) | 润肺止咳丸 | |
| CN103977296A (zh) | 一种治疗尿道炎的中药口服液及制备方法 | |
| CN104524225A (zh) | 一种治疗肾虚型腹部手术后尿潴留的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170426 |